You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
恆瑞醫藥跌幅再度擴大至6% 市值跌破3000億
格隆匯 08-23 09:51
格隆匯8月23日丨繼上週五跌停後,恆瑞醫藥(600276.SH)今日繼續下跌,盤中跌幅擴大至超6%至45.5元,股價創逾兩年新低,市值跌破3000億元。今年上半年,恆瑞醫藥實現營業收入約133億元,繼續保持了兩位數增速,但歸屬於上市公司股東的淨利潤一反常態,同比增速僅0.21%,為26.68億元。分季度看,二季度公司淨利潤還罕見地出現負增長。經營業績遠低於市場預期,再加上機構投資者大幅減倉,該股目前股價已較年初高點(97.16元)“腰斬”。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account